Q: Good day, can you please comment on the latest quarter AT just released? The numbers look great to me. Cheers
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: I have partial positions in efn and gsy. Disregarding everything but growth, would you combine them in gsy? Thanks.
Q: Hi Peter and Team,
Do you have any suggestions for a replacement for MDA?
Thanks,
Jordan
Do you have any suggestions for a replacement for MDA?
Thanks,
Jordan
Q: Hi Team, Sorry about just copying this info, but RBC is doing a better job than I could:
12:23 PM EDT, 05/03/2017 (MT Newswires) -- RBC Capital is initiating coverage on TSO3 with an Outperform, Speculative Risk rating and C$4.25 target. TSO3 has recently commercialized a proprietary and highly differentiated device for the sterilization of medical devices, particularly endoscopes, in healthcare settings, the brokerage reports, adding that the company is therefore uniquely positioned with its marketing partner, Getinge (a world leader in infection control sales). "We expect greater than ~40% returns over the next 12-months."
Price: 3.17, Change: +0.08, Percent Change: +2.6
Would you agree or disagree with RBC on TSO3?
Thanks, Chris
12:23 PM EDT, 05/03/2017 (MT Newswires) -- RBC Capital is initiating coverage on TSO3 with an Outperform, Speculative Risk rating and C$4.25 target. TSO3 has recently commercialized a proprietary and highly differentiated device for the sterilization of medical devices, particularly endoscopes, in healthcare settings, the brokerage reports, adding that the company is therefore uniquely positioned with its marketing partner, Getinge (a world leader in infection control sales). "We expect greater than ~40% returns over the next 12-months."
Price: 3.17, Change: +0.08, Percent Change: +2.6
Would you agree or disagree with RBC on TSO3?
Thanks, Chris
Q: What is your current
View of BUS at the
2.60$ level over the
Next 12 months ?
Thanks. Barry.
View of BUS at the
2.60$ level over the
Next 12 months ?
Thanks. Barry.
Q: Hello! I would appreciate your thoughts on FRII earnings.
Many thanks!
Many thanks!
Q: Your opinion on ZCL results released today.Thanks for your usual great services & views
Q: Please, Peter: Forward earnings for TMB look exceptionally good, ratings, too. TMB is much more than softwood lumber, including a lot of earnings coming from a specialized pulp (prices up, WTO ruled largely in Canada's favour with China in a tariff dispute)yet TMB has traded in a very NARROW range over the last 3 months or so and continues to do so. OK, TMB is a risk because of high debt... but can you explain the reason for the narrow trading range? I'm thinking it might be a big company like Fairfax, somehow able to buy and sell in a way that affects the price in this way but I don't know anything about how to dig further to get an answer to "why this range"?
Can you help?
Can you help?
Q: Hi Team, would you kindly provide your comments on Shopify's quarterly results this morning? Regards, Michael
Q: Your comments on the 2016 results, please, as well as the new acquisition. Does this explain today's drop?
Q: In just over 2 weeks with no particular changes in the world or the North American economy, including the market positioning or financial results of CRH; the stock has dropped over 35%! Is there something I just can't see or read into the latest Quarterly report or is there something relative to the MI positions that are not apparent in the Statements??
Q: Hi
I have some new money to put to work. Which three names in the growth portfolio would you suggest buying at current levels?
Thanks,
Curtis
I have some new money to put to work. Which three names in the growth portfolio would you suggest buying at current levels?
Thanks,
Curtis
Q: Hello,
I'm looking at initiating a position in either KXS or PHO for an aggressive growth pick within my TFSA. I like the larger size and scope of KXS but am intrigued by the increasing volume of PHO which seems to be missing from the KXS chart. I'm also less familiar with PHO (no 5i Report) - could you quickly highlight their customer base, and which company/industry/product is responsible for their current stock profile?
Thanks,
Cam.
I'm looking at initiating a position in either KXS or PHO for an aggressive growth pick within my TFSA. I like the larger size and scope of KXS but am intrigued by the increasing volume of PHO which seems to be missing from the KXS chart. I'm also less familiar with PHO (no 5i Report) - could you quickly highlight their customer base, and which company/industry/product is responsible for their current stock profile?
Thanks,
Cam.
-
Kinaxis Inc. (KXS $177.44)
-
Shopify Inc. Class A Subordinate Voting Shares (SHOP $229.03)
-
goeasy Ltd. (GSY $138.72)
-
Altus Group Limited (AIF $56.68)
Q: Hi team, I'm looking for 4 suggestions of equal weight to add to my tfsa. Looking to be farely aggressive in this account. Cheers
Q: Hi guys,
I'm curious to know what names get you really excited nowadays. Are there any comapnies that you see really moving in the next 12-24 months? I'm looking for places to move the more speculative portion of my portfolio (~10%).
I'm curious to know what names get you really excited nowadays. Are there any comapnies that you see really moving in the next 12-24 months? I'm looking for places to move the more speculative portion of my portfolio (~10%).
Q: Could I have your views on this small company. It appears to be one of the few companies in this cannabis sector offering a dividend. Does offering a dividend make it less risky or should I not even think of buying this one and stick with the bigger companies like Canopy Growth. Tnx
Q: I noticed you like the company...and I am thinking taking a TSFA position,but am worried about the number of shares that come due after the lock-up period.
You have more info about this and what are your thought about FRII is it getting interesting for you to put in the growth portfolio?
You have more info about this and what are your thought about FRII is it getting interesting for you to put in the growth portfolio?
Q: How would the Growth Portfolio react if there was a 5% correction in the markets? Which stocks would be more volatile than the others? Thanks.
-
Bank of Montreal (BMO $184.56)
-
BCE Inc. (BCE $33.02)
-
Sun Life Financial Inc. (SLF $87.40)
-
TELUS Corporation (T $18.58)
-
Fortis Inc. (FTS $71.63)
-
Brookfield Renewable Partners L.P. (BEP.UN $37.44)
-
WSP Global Inc. (WSP $260.02)
-
Cineplex Inc. (CGX $11.09)
-
iShares Diversified Monthly Income ETF (XTR $11.81)
Q: My son is currently 39 years old and is trying to develop a solid diversified portfolio. All of his holdings are in his RRSP except for some money in a Tangerine International growth fund which is in his TFSA. He has some new funds to add to his holdings. Could you please recommend some companies from your model portfolios that would add more diversification to his portfolio keeping in mind his relatively long investment horizon. As always, thanks for your advice.
Q: Hi, The recent large acquisition seems to have garnered strong market interest. After staying at $2.05-$2.15 level for a few days, stock price has taken off to new highs over last week, on heavy volume. Your recent comments indicate some concern over debt financing and have kept me on the sidelines. Am I missing the boat and is it worth starting with a partial position at these levels?